Company / Debt per Share
Kura Oncology, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.12
FY2025
5-year range
$0.12 / $0.14
FY2021-FY2025
Trend
-3.2%
vs FY2024
Sector context
#77 of 82
Health Care
What the data says
Among 82 Health Care companies, Kura Oncology, Inc. is in the top 6% for debt per share. Debt per Share has fluctuated over the past 9 years, ranging from $0.08 in FY2020 to $0.39 in FY2016.
Based on SEC 10-K filings.
0.12 in FY2025 with a 5-year CAGR of +9.1%.
Improved from $0.13 to $0.12 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 82This company $0.12 Sector average $151.59
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 3.2% year-over-year.
- Ranks #77 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2016.
- Lowest debt per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | -3.2% |
| FY2024 | $0.13 | +0.5% |
| FY2023 | $0.13 | -6.8% |
| FY2022 | $0.14 | - |
| FY2021 | - | - |
| FY2020 | $0.08 | -53.7% |
| FY2019 | $0.17 | -18.9% |
| FY2018 | $0.21 | -11.0% |
| FY2017 | $0.24 | -38.8% |
| FY2016 | $0.39 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026